Author: Daniel B Larremore; Bailey K Fosdick; Kate M Bubar; Sam Zhang; Stephen M Kissler; C. Jessica E. Metcalf; Caroline Buckee; Yonatan Grad
Title: Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys Document date: 2020_4_20
ID: c4cs14ja_108
Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint Figure S1 : Uncertainty of population seroprevalence estimates as a function of number of samples and true population rate. Uncertainty, represented by the width of 90% credible intervals, is presented as ± seroprevalence percentage points in heatmaps and for selected seroprevalence values, based on a serological tests with (A,D) 93.8% sensitivity and 95.6% specificity, .....
Document: is the (which was not peer-reviewed) The copyright holder for this preprint Figure S1 : Uncertainty of population seroprevalence estimates as a function of number of samples and true population rate. Uncertainty, represented by the width of 90% credible intervals, is presented as ± seroprevalence percentage points in heatmaps and for selected seroprevalence values, based on a serological tests with (A,D) 93.8% sensitivity and 95.6% specificity, matching the claims of a Cellex test, (B,E) 97.2% sensitivity and 100% specificity, matching the claims of an Aytu IgG test, (C,F) 100% sensitivity and specificity, representing an ideal test. complementing the results for a test with 93% sensitivity and 97.5% specificity shown in the main text (Fig. 2) . See Supplementary Table S1 for details on serological test kits.
Search related documents:
Co phrase search for related documents- population seroprevalence and serological test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- population seroprevalence and seroprevalence value: 1, 2
- population seroprevalence and specificity 100 sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9
- population seroprevalence and specificity sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48
- population seroprevalence and Supplementary Table s1: 1, 2
- population seroprevalence and test kit: 1, 2, 3
- population seroprevalence estimate and serological test: 1, 2
- population seroprevalence estimate and specificity sensitivity: 1, 2, 3
- serological test and specificity 100 sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- serological test and specificity sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- serological test and Supplementary Table s1: 1, 2
- serological test and test kit: 1, 2, 3
- seroprevalence value and specificity 100 sensitivity: 1
- seroprevalence value and specificity sensitivity: 1, 2, 3, 4, 5, 6
- specificity 100 sensitivity and Supplementary Table s1: 1, 2
- specificity 100 sensitivity and test kit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- specificity sensitivity and Supplementary Table s1: 1, 2, 3, 4
- specificity sensitivity and test kit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- Supplementary Table s1 and test kit: 1, 2
Co phrase search for related documents, hyperlinks ordered by date